CHINA BIOPHARMACEUTICALS HOLDINGS INC

China Biopharmaceuticals Holdings Inc. operates in the Pharmaceutical Preparations SIC realm, specializing in the development, manufacturing, and distribution of innovative drug formulations and therapeutic injectables tailored to hospitals, large clinic networks, and government healthcare systems across Greater China and select export markets. Its vertically integrated supply chain encompasses active pharmaceutical ingredient sourcing, formulation science, and regulatory-compliant production lines designed to serve high-volume institutional customers seeking reliable generics and specialty biopharma alternatives. The company navigates material risks including stringent PRC and international regulatory oversight, pricing pressures from healthcare reform, and capital intensity tied to clinical trials, facility compliance, and shifts in raw-material availability. The most recent filing, a Form 10-Q submitted in October 1999, underscores the need for updated disclosures and ongoing transparency for investors tracking this profile, so explore live SEC filings on Earnings Feed for the latest developments.

Source: Earnings Feed research · last updated 11/24/2025